ClinicalTrials.gg
CompletedNCT06882863Updated Nov 16, 2026

A Nurse-led Motivational Interviewing Intervention Targeting Sedentary Behavior in Patients With Severe COPD: An Exploratory Pilot Study

An interventional study of Motivational interviewing in Chronic Obstructive Pulmonary Disease (COPD), sponsored by Zealand University Hospital. Completed at 1 site in Denmark. Open to participants aged 65 Years and older. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Zealand University Hospital · Not applicable, Interventional, and Supportive care

Updated Nov 16, 2026Now CompletedPrimary completion moved+3 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
11
Allocation
Not applicable
Ages
65 Years and older
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-17

Among 243 studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark — 33 open to participants now, 42 under way, 8 of them phase 3. Pulmonary Disease, Chronic Obstructive · Denmark.

Enrollment
195th of 209
11 · median 182
Started
2025
with 12 others
No phase
84 of 243
14 open now
Registered
223rd of 243
by date

Among the 243 studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark, this one is the 195th largest by enrollment of the 209 interventional ones that give a count, is one of 13 that started in 2025, is one of 84 with no phase, and was the 223rd registered.

Pulmonary Disease, Chronic Obstructive

5,522 studies on the registry are indexed under Pulmonary Disease, Chronic Obstructive; 856 are open to participants now.

Browse Pulmonary Disease, Chronic Obstructive studies →

Open to participants now

33 of the 243 studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark are open now. Recruiting first, the newest first:

28 more — sign in →

All 33 open studies →

A study can be open while its sites in Denmark have not opened yet or have stopped. Only those recruiting at a site in Denmark →

Who these studies take

Of the 558 Pulmonary Disease, Chronic Obstructive studies recruiting now, 307 (55%) set no upper age limit and 82 (15%) stop at 75 or younger; 29 take children under 18; 88 take healthy volunteers.

This study: 65 Years and older · all sexes · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 243 studies in Pulmonary Disease, Chronic Obstructive with a site in Denmark, or all of them as a file.
02

Study summary

This intervention development and pilot study aimed to develop and evaluate a nurse-led motivational intervention designed to reduce sedentary behavior among patients with severe chronic obstructive pulmonary disease (COPD).

A total of 11 patients were enrolled. The intervention consisted of an individualized, home-based counseling session delivered by a trained nurse, integrating principles of Motivational Interviewing (MI) and Cognitive Behavioral Therapy (CBT). The intervention focused on identifying individual barriers, strengthening motivation, and establishing realistic, patient-centered goals to reduce sedentary time in everyday life.

The pilot study explored the acceptability and practical application of the intervention from both patient and nurse perspectives. Sedentary behavior was objectively assessed using thigh-worn accelerometers over seven consecutive days, alongside patient-reported outcome measures and evaluations of the intervention experience.

Findings from the study informed further refinement of the intervention, its delivery, and the outcome assessment procedures in preparation for a subsequent randomized controlled trial (RCT).

Read the detailed description

This intervention development and pilot study aimed to develop and evaluate a nurse-led motivational intervention targeting sedentary behavior in patients with severe chronic obstructive pulmonary disease (COPD).

Patients with severe COPD often experience breathlessness, fatigue, and functional limitations that contribute to prolonged sedentary time. High levels of sedentary behavior may negatively affect physical functioning, health outcomes, and quality of life. Although pulmonary rehabilitation is an important component of COPD management, some patients experience barriers to participation, including symptom burden, physical limitations, and fear of worsening breathlessness. Individually tailored behavioral interventions may offer an additional approach to supporting patients in reducing sedentary behavior through manageable changes in daily routines.

The intervention was developed to support individualized behavioral change and incorporated principles from Motivational Interviewing (MI) and Cognitive Behavioral Therapy (CBT). It was designed to be delivered by trained nurses and to address patients' individual needs, preferences, capabilities, and everyday circumstances.

The pilot study included 11 patients with severe COPD recruited from a pulmonary outpatient setting. Participants were offered an individualized, nurse-led counseling session in their own homes. During the session, the nurse explored the patient's current sedentary behavior, perceived barriers to movement, personal motivations, and opportunities for change. Together, the nurse and patient identified realistic and meaningful goals aimed at interrupting prolonged sitting and incorporating additional movement into everyday activities. The intervention emphasized achievable behavioral adjustments rather than structured exercise, recognizing the physical limitations and symptom burden associated with severe COPD.

Sedentary behavior was objectively assessed using a thigh-worn accelerometer over seven consecutive days. Patient-reported outcome measures were also collected to characterize participants' health status and symptom burden. These assessments provided information about the target population and the practical considerations associated with data collection.

The pilot evaluation focused on the acceptability, relevance, and practical delivery of the intervention. Patient feedback was collected to explore experiences of the counseling session, perceived relevance of the individualized goals, and barriers to behavioral change. The nurse delivering the intervention also evaluated its applicability in clinical practice, including the counseling structure, patient engagement, and practical considerations related to intervention delivery.

Additional aspects of the evaluation included recruitment, participant retention, adherence to accelerometer measurements, and the acceptability and burden of patient-reported outcome assessments. These findings were used to identify potential improvements to intervention materials, counseling procedures, and data collection methods.

The study provided preliminary insights into the implementation and acceptability of a nurse-led behavioral intervention targeting sedentary behavior in patients with severe COPD. As a small, single-arm pilot study, it was not designed to establish intervention effectiveness. Instead, the findings informed further development and refinement of the intervention and the methodological procedures for a subsequent randomized controlled trial (RCT).

The overall objective is to develop a clinically relevant, patient-centered nursing intervention that can support sustainable reductions in sedentary behavior among individuals living with severe COPD.

03

Conditions studied

  • Chronic Obstructive Pulmonary Disease (COPD)
04

Who can participate

Ages eligible
65 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Diagnosed with severe confirmed by a healthcare provider.
  • Aged 65 years or older at the time of enrollment.
  • Self-reported sedentary behavior of at least 5 hours per day.
  • Able to provide and participate in a home-based interview.
  • Not currently enrolled in a structured pulmonary rehabilitation program.

Exclusion criteria

Exclusion Criteria:

  • Severe cognitive impairment that prevents meaningful participation in the motivational interview.
  • Physical disability that completely prevents movement and makes physical activity recommendations irrelevant.
  • Severe comorbidities with a of less than six months.
  • Inability to understand or communicate in Danish.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

COPD

Chronic obstructive pulmonary disease: long-term lung disease that makes it hard to breathe out, including emphysema and chronic bronchitis.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Life expectancy

The study doctor’s estimate of how long someone is likely to live. Criteria use it so that people can stay in the study long enough for it to answer its question.

05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
11 participants (actual)

Study arms

  • Experimental
    Feasibility

    This feasibility study involves a single-arm intervention where patients with severe COPD receive nurse-led motivational interviews to reduce sedentary behavior. Participants recieve one 60 minute intervention, focusing on identifying barriers, setting small activity goals, and building motivation using motivational interviewing (MI) and Cognitive Behavioral Therapy (CBT) techniques. Participants wear accelerometers for seven days before the intervention to measure changes in sedentary time. The study assesses recruitment feasibility, adherence, and patient acceptability, informing refinements before a future randomized controlled trial (RCT).

    Behavioral: Motivational interviewing

Interventions

  • BehavioralMotivational interviewing

    This intervention consists of a single nurse-led motivational interview aimed at reducing sedentary behavior in patients with severe COPD. The session, conducted in the patient's home, lasts approximately 60 minutes and focuses on identifying personal barriers, exploring motivation, and setting small, realistic goals to reduce sedentary time. Unlike traditional pulmonary rehabilitation, this intervention does not involve structured exercise but instead uses motivational interviewing (MI) techniques to encourage gradual behavior change in daily routines. Before the intervention, patients wear an accelerometer for seven days to objectively measure baseline sedentary time. The study assesses feasibility, patient engagement, and adherence to determine whether the approach is suitable for a larger randomized controlled trial (RCT).

06

What researchers measure

Primary outcomes

  1. Feasibility and acceptability of the intervention

    Measured by the number of participants who successfully complete the intervention.

    Time frame: From enrollment to one week post-intervention

Secondary outcomes

  1. questionnaire

    Measured by the number of participants who successfully complete the provided questionnaire SF-12

    Time frame: From enrollment to one week post-intervention

  2. questionnaire

    Measured by the number of participants who successfully complete the provided questionnaire CRQ

    Time frame: From enrollment to one week post-intervention

  3. questionnaire

    Measured by the number of participants who successfully complete the provided questionnaire HADS.

    Time frame: From enrollment to one week post-intervention

07

Study locations

1 site
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Mar 2025 to primary completion in Jun 2026, 14 months.

Of 1,095 non-industry interventional studies with no phase under Pulmonary Disease, Chronic Obstructive, half reached primary completion within 22 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's 14 months is below that.

Counting every sponsor, half of 1,183 studies reached it within 22 months; a quarter within 10 and three quarters within 39.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 16, 2026: primary completion Jul 2027 → Jun 2026 and completion Jul 2027 → Jun 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Mar 11, 2025
First posted
Mar 19, 2025
StartActual
Mar 19, 2025
Primary completionActual
Jun 1, 2026was Jul 2027
CompletionActual
Jun 1, 2026was Jul 2027
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Completed
changed Nov 16, 2026
Primary completion
Jul 2027→Jun 1, 2026 (actual)
Nov 16, 2026
Study completion
Jul 2027→Jun 1, 2026 (actual)
Nov 16, 2026
Enrollment
10 (estimated)→11 (actual)
Nov 16, 2026
Title
Reducing Sedentary Behavior in Patients with Severe COPD: a Feasibility Study on Nurse-Led Motivational Intervention→A Nurse-led Motivational Interviewing Intervention Targeting Sedentary Behavior in Patients With Severe COPD: An Exploratory Pilot Study
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    Enrolling by invitation→Completed
    Primary completion Jul 2027→Jun 1, 2026 (now actual)
    Study completion Jul 2027→Jun 1, 2026 (now actual)
    Enrollment 10 (estimated)→11 (actual)
    Title Reducing Sedentary Behavior in Patients with Severe COPD: a Feasibility Study on Nurse-Led Motivational Intervention→A Nurse-led Motivational Interviewing Intervention Targeting Sedentary Behavior in Patients With Severe COPD: An Exploratory Pilot Study
    + 2 other changes: oversight details and description

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06882863
Responsible party
Sponsor
First posted
Mar 19, 2025
Start date
Mar 19, 2025
Primary completion
Jun 1, 2026
Completion
Jun 1, 2026
Last update
Nov 16, 2026

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion